Key result
Matrix paradigm-driven ablation enables large, predictable lesions to optimize safety and efficacy in refractory VT.
Why the study?
Patients with VT refractory to RF ablation and PFA continue to experience recurrent VT potentially due to limitations in lesion size or scar penetration, creating a need for predictable lesion sizing in animal models and clinical validation of the Matrix paradigm.
Population
Animal models and patients with VT refractory to RF ablation and PFA
Answers are grounded in this paper and cite their sources.
Recurrent VT after ablation warrants caution with current lesion strategies; leaves open validation of predictable sizing in trials.
Patients with VT refractory to RF ablation and PFA continue to be troubled with recurrent VT, resulting in symptoms, ATP, or ICD shocks. This may be due to limitations of lesion size or penetration into the scar tissues. There is a pronounced need for Predictable Lesion sizing in animal models and clinical validation of the paradigm Matrix in patients.
No takes yet. Share an insight, caveat, or question.
Packer et al. (2026) studied this question. Matrix paradigm-driven ablation enables the creation of large, predictably sized lesions to optimize safety and efficacy in patients with refractory ventricular tachycardia.
Synapse has enriched 10 related papers. Consider them for comparative context: